[go: up one dir, main page]

IN176897B - - Google Patents

Info

Publication number
IN176897B
IN176897B IN356BO1993A IN176897B IN 176897 B IN176897 B IN 176897B IN 356BO1993 A IN356BO1993 A IN 356BO1993A IN 176897 B IN176897 B IN 176897B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Indravadan Ambalal Mr Modi
Ramanbhai Becharbhai Mr Patel
Original Assignee
Cadila Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Lab Ltd filed Critical Cadila Lab Ltd
Priority to IN356BO1993 priority Critical patent/IN176897B/en
Priority to US08/324,584 priority patent/US5616593A/en
Priority to AU75992/94A priority patent/AU686656B2/en
Priority to ZA948348A priority patent/ZA948348B/xx
Priority to EP94116731A priority patent/EP0709098A1/fr
Priority to CN94117602A priority patent/CN1121412A/zh
Priority to CA002134610A priority patent/CA2134610A1/fr
Publication of IN176897B publication Critical patent/IN176897B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN356BO1993 1993-10-29 1993-10-29 IN176897B (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IN356BO1993 IN176897B (fr) 1993-10-29 1993-10-29
US08/324,584 US5616593A (en) 1993-10-29 1994-10-18 Compositions containing piperine
AU75992/94A AU686656B2 (en) 1993-10-29 1994-10-21 Compositions containing piperine
ZA948348A ZA948348B (en) 1993-10-29 1994-10-24 compositions containing piperine
EP94116731A EP0709098A1 (fr) 1993-10-29 1994-10-24 Compositions contenant de la piperine
CN94117602A CN1121412A (zh) 1993-10-29 1994-10-28 含胡椒碱的组合物
CA002134610A CA2134610A1 (fr) 1993-10-29 1994-10-28 Composition a base de piperine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN356BO1993 IN176897B (fr) 1993-10-29 1993-10-29
CN94117602A CN1121412A (zh) 1993-10-29 1994-10-28 含胡椒碱的组合物

Publications (1)

Publication Number Publication Date
IN176897B true IN176897B (fr) 1996-09-28

Family

ID=37087796

Family Applications (1)

Application Number Title Priority Date Filing Date
IN356BO1993 IN176897B (fr) 1993-10-29 1993-10-29

Country Status (7)

Country Link
US (1) US5616593A (fr)
EP (1) EP0709098A1 (fr)
CN (1) CN1121412A (fr)
AU (1) AU686656B2 (fr)
CA (1) CA2134610A1 (fr)
IN (1) IN176897B (fr)
ZA (1) ZA948348B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN186315B (fr) * 1996-12-12 2001-08-04 Panacea Biotec Ltd
GT199800127A (es) * 1997-08-29 2000-02-01 Combinaciones terapeuticas.
ID24275A (id) * 1997-08-29 2000-07-13 Pfizer Prod Inc Terapi kombinasi
US5916595A (en) * 1997-12-12 1999-06-29 Andrx Pharmaceutials, Inc. HMG co-reductase inhibitor
US8679534B2 (en) * 1997-12-12 2014-03-25 Andrx Labs, Llc HMG-CoA reductase inhibitor extended release formulation
US20040029962A1 (en) * 1997-12-12 2004-02-12 Chih-Ming Chen HMG-COA reductase inhibitor extended release formulation
EP0935964A1 (fr) * 1998-02-12 1999-08-18 Panacea Biotec Limited Compositions pharmaceutiques contenant des anti-inflammatoires non steroidiens et de la piperine
GB9812426D0 (en) * 1998-06-10 1998-08-05 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
US6054585A (en) * 1998-12-23 2000-04-25 Sabinsa Corporation Process for making high purity piperine for nutritional use
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
CA2390301A1 (fr) * 1999-11-08 2001-05-17 Andrx Corporation Formulation d'inhibiteur de la hmg-coa reductase a liberation lente
IL141438A0 (en) * 2000-02-23 2002-03-10 Pfizer Prod Inc Method of increasing the bioavailability and tissue penetration of azithromycin
WO2001089571A2 (fr) * 2000-05-19 2001-11-29 Sabinsa Corporation Methode permettant d'augmenter la biodisponibilite de nutriments et preparations pharmaceutiques renfermant de la tetrahydropiperine et des analogues et derives de tetrahydropiperine
AU7440301A (en) * 2000-06-26 2002-01-08 Khamar, Bakulesh Mafatlal Chemosensitizer
IL155291A0 (en) * 2000-10-16 2003-11-23 Neopharm Inc Liposomal formulation of mitoxantrone
IT1320180B1 (it) * 2000-12-29 2003-11-26 Hunza Di Marazzita Maria Carme Preparazioni nutrizionali e terapeutiche dotate di attivita'antiossidante ed in grado di controllare gli eccessi ponderali e
US20030068276A1 (en) * 2001-09-17 2003-04-10 Lyn Hughes Dosage forms
GB2403411B (en) * 2002-04-04 2006-04-12 Bakulesh Mafatlal Khamar Pharmaceutical compositions containing antiretroviral protease inhibitor with improved bioavailability
US20070249537A1 (en) * 2003-01-23 2007-10-25 Supernus Pharmaceuticals, Inc. Absorption enhancing agents
AU2003223111A1 (en) * 2003-03-31 2004-10-25 Council Of Scientific And Industrial Research Use of cuminum cyminum extract and piperine for potentiation of bioefficacy of anti infectives
US20070087055A1 (en) * 2005-10-14 2007-04-19 David Jan Directly compressible extended release alprazolam formulation
EP2011495A1 (fr) * 2007-07-03 2009-01-07 Sygnis Bioscience GmbH & Co. KG Utilisation de pipérine et dérivés correspondants pour la thérapie de conditions neurologiques
US20090297622A1 (en) * 2008-01-01 2009-12-03 Khorshid Faten A Separation and formulation of bioactive fraction and subfraction from camel urine work as anticancer agent
SI2263681T1 (sl) 2009-06-17 2015-11-30 Khorshid, Fatin A. King Abdulaziz University, Kau Ločitev in formuliranje bioaktivne frakcije in podfrakcije iz predelave kameljega urina kot sredstva proti raku
WO2013108254A1 (fr) 2012-01-19 2013-07-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Formulation et méthode destinées à augmenter la biodisponibilité orale de médicaments
WO2019038454A1 (fr) * 2017-08-25 2019-02-28 Brilliantiq Ab Gomme à mâcher fonctionnelle comprenant des phytonutriments et des herbes adaptogènes
WO2019058386A1 (fr) 2017-09-19 2019-03-28 Cipla Limited Compositions comprenant de l'ibrutinib et un alcaloïde ayant une biodisponibilité améliorée
DE202024105876U1 (de) 2023-11-16 2024-10-29 Alcus Med Gmbh Kombinationspräparat zur diätetischen Behandlung von Magen- und Darmbeschwerden durch Helicobacter Pylori Infektionen

Also Published As

Publication number Publication date
ZA948348B (en) 1995-06-14
CN1121412A (zh) 1996-05-01
AU7599294A (en) 1995-05-18
CA2134610A1 (fr) 1995-04-30
AU686656B2 (en) 1998-02-12
EP0709098A1 (fr) 1996-05-01
US5616593A (en) 1997-04-01

Similar Documents

Publication Publication Date Title
TW229287B (fr)
FR2707024B1 (fr)
FR2702922B1 (fr)
FR2706956B1 (fr)
EP0721427A4 (fr)
EP0725461A3 (fr)
EP0702629A4 (fr)
FR2706919B3 (fr)
IN188869B (fr)
ATA104693A (fr)
FR2706910B1 (fr)
IN187370B (fr)
FR2706832B1 (fr)
IN187302B (fr)
CU22428A3 (fr)
GB9316971D0 (fr)
IN186566B (fr)
GB9317366D0 (fr)
IN174407B (fr)
IN185987B (fr)
ECSDI930096S (fr)
IN183057B (fr)
IN182985B (fr)
CU22427A3 (fr)
ECSMU930028U (fr)